Amlodipine Besylate
Product Images NDC 64725-0238

4 FDA label images from Tya Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 64725-0238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0238)

Label Image (64725 0238)
Label for Amlodipine Besylate 5 mg tablets in a 100-count bottle. The label includes prescription-only status, a lot number placeholder, expiration date placeholder, original manufacturer Invagen, and repackaging information by TYA Pharmaceuticals with contact details in Tallahassee, FL. A barcode is also visible.*
FDA Label Image

8352ab43-figure-01 (8352ab43 Figure 01)

8352ab43-figure-01 (8352ab43 Figure 01)
Chemical structure diagram of the active ingredient Amlodipine Besylate, showing its molecular arrangement and functional groups.*
FDA Label Image

8352ab43-figure-02 (8352ab43 Figure 02)

8352ab43-figure-02 (8352ab43 Figure 02)
A Kaplan-Meier event rate curve comparing Amlodipine vs. Placebo over 24 months with the y-axis showing event rate and the x-axis showing time in months. The graph includes hazard ratio and p-value statistics indicating a difference between treatments.*
FDA Label Image

8352ab43-figure-03 (8352ab43 Figure 03)

8352ab43-figure-03 (8352ab43 Figure 03)
A forest plot illustrating hazard ratios with 95% confidence intervals comparing Amlodipine and placebo across various patient subgroups, including overall, age, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The plot shows relative risk favoring either Amlodipine or placebo along the x-axis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.